1
|
Su F, Descher H, Bui-Hoang M, Stuppner H, Skvortsova I, Rad EB, Ascher C, Weiss A, Rao Z, Hohloch S, Koeberle SC, Gust R, Koeberle A. Iron(III)-salophene catalyzes redox cycles that induce phospholipid peroxidation and deplete cancer cells of ferroptosis-protecting cofactors. Redox Biol 2024; 75:103257. [PMID: 38955113 PMCID: PMC11263665 DOI: 10.1016/j.redox.2024.103257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2024] [Revised: 06/11/2024] [Accepted: 06/24/2024] [Indexed: 07/04/2024] Open
Abstract
Ferroptosis, a lipid peroxidation-driven cell death program kept in check by glutathione peroxidase 4 and endogenous redox cycles, promises access to novel strategies for treating therapy-resistant cancers. Chlorido [N,N'-disalicylidene-1,2-phenylenediamine]iron (III) complexes (SCs) have potent anti-cancer properties by inducing ferroptosis, apoptosis, or necroptosis through still poorly understood molecular mechanisms. Here, we show that SCs preferentially induce ferroptosis over other cell death programs in triple-negative breast cancer cells (LC50 ≥ 0.07 μM) and are particularly effective against cell lines with acquired invasiveness, chemo- or radioresistance. Redox lipidomics reveals that initiation of cell death is associated with extensive (hydroper)oxidation of arachidonic acid and adrenic acid in membrane phospholipids, specifically phosphatidylethanolamines and phosphatidylinositols, with SCs outperforming established ferroptosis inducers. Mechanistically, SCs effectively catalyze one-electron transfer reactions, likely via a redox cycle involving the reduction of Fe(III) to Fe(II) species and reversible formation of oxo-bridged dimeric complexes, as supported by cyclic voltammetry. As a result, SCs can use hydrogen peroxide to generate organic radicals but not hydroxyl radicals and oxidize membrane phospholipids and (membrane-)protective factors such as NADPH, which is depleted from cells. We conclude that SCs catalyze specific redox reactions that drive membrane peroxidation while interfering with the ability of cells, including therapy-resistant cancer cells, to detoxify phospholipid hydroperoxides.
Collapse
Affiliation(s)
- Fengting Su
- Michael Popp Institute, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria
| | - Hubert Descher
- Institute of Pharmacy/Pharmaceutical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria
| | - Minh Bui-Hoang
- Michael Popp Institute, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria; Unit of Pharmacognosy, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria
| | - Hermann Stuppner
- Unit of Pharmacognosy, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria
| | - Ira Skvortsova
- EXTRO-Lab, Department of Therapeutic Radiology and Oncology, Medical University of Innsbruck, Innsbruck, Austria
| | - Ehsan Bonyadi Rad
- Michael Popp Institute, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria
| | - Claudia Ascher
- Institute for Biomedical Aging Research, University of Innsbruck, Innsbruck, Austria
| | - Alexander Weiss
- Institute for Biomedical Aging Research, University of Innsbruck, Innsbruck, Austria
| | - Zhigang Rao
- Michael Popp Institute, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria
| | - Stephan Hohloch
- Institute for General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innsbruck, Austria
| | - Solveigh C Koeberle
- Michael Popp Institute, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria
| | - Ronald Gust
- Institute of Pharmacy/Pharmaceutical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria
| | - Andreas Koeberle
- Michael Popp Institute, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria.
| |
Collapse
|
2
|
Bernkop-Schnürch A, Hermann M, Leitner D, Talasz H, Descher HA, Hohloch S, Gust R, Kircher B. Transferrin Receptor-Mediated Cellular Uptake of Fluorinated Chlorido[ N, N'-bis(salicylidene)-1,2-phenylenediamine]iron(III) Complexes. ACS OMEGA 2024; 9:35394-35407. [PMID: 39184483 PMCID: PMC11340086 DOI: 10.1021/acsomega.4c01314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/09/2024] [Revised: 06/20/2024] [Accepted: 06/28/2024] [Indexed: 08/27/2024]
Abstract
Fluorinated chlorido[salophene]iron(III) complexes (salophene = N,N'-bis(salicylidene)-1,2-phenylenediamine) are promising anticancer agents. Apoptosis and necrosis induction have already been described as part of their mode of action. However, the involvement of ferroptosis in cell death induction, as confirmed for other chlorido[salophene]iron(III) complexes, has not yet been investigated. Furthermore, the mechanism of cellular uptake of these compounds is unknown. Therefore, the biological activity of the fluorescent chlorido[salophene]iron(III) complexes with a fluorine substituent at positions 3, 4, 5, or 6 at the salicylidene moieties (C1-C4) was evaluated in malignant and nonmalignant cell lines with focus on the involvement of the transferrin receptor-1 (TfR-1) in cellular uptake, the influence of the complexes on mitochondrial function, and the analysis of the molecular mechanism of cell death. All complexes significantly decreased the metabolic activity in the tested ovarian cancer (A2780, A2780cis), breast cancer (MDA-MB 231), and leukemia (HL-60) cell lines, while the nonmalignant human stroma cell line HS-5 at a concentration of 0.5 μM, which represents the IC50 of the complexes in most of the used tumorigenic cell lines, was not affected. The mitochondrial function was impaired, as evidenced by a reduced mitochondrial membrane potential ΔΨm and decreased mitochondrial activity. Besides apoptosis and necroptosis, ferroptosis was identified as part of the mode of action. It was further demonstrated for the first time that fluorinated chlorido[salophene]iron(III) complexes downregulate TfR-1 expression, comparable to ferristatin II, an iron transport inhibitor that acts via TfR-1 degradation. FerroOrange staining further indicated that the complexes strongly increased the intracellular iron(II) level as a driving force to induce ferroptosis. In conclusion, these fluorinated chlorido[salophene]iron(III) complexes are potent, tumor cell-specific chemotherapeutic agents, with the potential to treat various types of cancers.
Collapse
Affiliation(s)
- Astrid
Dagmar Bernkop-Schnürch
- Department
of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI—Center
for Molecular Biosciences Innsbruck, CCB—Center for Chemistry
and Biomedicine, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria
| | - Martin Hermann
- Department
of Anesthesiology and Critical Care Medicine, Medical University of Innsbruck, Anichstraße 35, 6020 Innsbruck, Austria
| | - Daniel Leitner
- Department
of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria
| | - Heribert Talasz
- Biocenter,
Institute of Medical Biochemistry, Protein Core Facility, Medical University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria
| | - Hubert Aaron Descher
- Department
of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI—Center
for Molecular Biosciences Innsbruck, CCB—Center for Chemistry
and Biomedicine, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria
| | - Stephan Hohloch
- Department
of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria
| | - Ronald Gust
- Department
of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI—Center
for Molecular Biosciences Innsbruck, CCB—Center for Chemistry
and Biomedicine, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria
| | - Brigitte Kircher
- Immunobiology
and Stem Cell Laboratory, Department of Internal Medicine V (Hematology
and Oncology), Medical University of Innsbruck, Anichstraße 35, 6020 Innsbruck, Austria
- Tyrolean
Cancer Research Institute, Innrain 66, 6020 Innsbruck, Austria
| |
Collapse
|
3
|
Bernkop-Schnürch A, Chavooshi D, Descher HA, Leitner D, Talasz H, Hermann M, Wurst K, Hohloch S, Gust R, Kircher B. Design, Synthesis, Electrochemical, and Biological Evaluation of Fluorescent Chlorido[ N, N'-bis(methoxy/hydroxy)salicylidene-1,2-bis(4-methoxyphenyl)ethylenediamine]iron(III) Complexes as Anticancer Agents. J Med Chem 2023; 66:15916-15925. [PMID: 38013413 PMCID: PMC10726350 DOI: 10.1021/acs.jmedchem.3c01359] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2023] [Revised: 11/02/2023] [Accepted: 11/15/2023] [Indexed: 11/29/2023]
Abstract
The impact of methoxy and hydroxyl groups at the salicylidene moiety of chlorido[N,N'-bis(methoxy/hydroxy)salicylidene-1,2-bis(4-methoxyphenyl)ethylenediamine]iron(III) complexes was evaluated on human MDA-MB 231 breast cancer and HL-60 leukemia cells. Methoxylated complexes (C1-C3) inhibited proliferation, migration, and metabolic activity in a concentration-dependent manner following the rank order: C2 > C3 > C1. In particular, C2 was highly cytotoxic with an IC50 of 4.2 μM which was 6.6-fold lower than that of cisplatin (IC50 of 27.9 μM). In contrast, hydroxylated complexes C4-C6 were almost inactive up to the highest concentration tested due to lack of cellular uptake. C2 caused a dual mode of cell death, ferroptosis, and necroptosis, whereby at higher concentrations, ferroptosis was the preferred form. Ferroptotic morphology and the presence of ferrous iron and lipid reactive oxygen species proved the involvement of ferroptosis. C2 was identified as a promising lead compound for the design of drug candidates inducing ferroptosis.
Collapse
Affiliation(s)
- Astrid
Dagmar Bernkop-Schnürch
- Department
of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI−Center
for Molecular Biosciences Innsbruck, CCB—Center for Chemistry
and Biomedicine, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria
| | - Donja Chavooshi
- Department
of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI−Center
for Molecular Biosciences Innsbruck, CCB—Center for Chemistry
and Biomedicine, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria
- Immunobiology
and Stem Cell Laboratory, Department of Internal Medicine V (Hematology
and Oncology), Medical University of Innsbruck, Anichstraße 35, 6020 Innsbruck, Austria
| | - Hubert Aaron Descher
- Department
of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI−Center
for Molecular Biosciences Innsbruck, CCB—Center for Chemistry
and Biomedicine, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria
| | - Daniel Leitner
- Department
of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria
| | - Heribert Talasz
- Biocenter,
Institute of Medical Biochemistry, Protein Core Facility, Medical University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria
| | - Martin Hermann
- Department
of Anesthesiology and Critical Care Medicine, Medical University of Innsbruck, Anichstraße 35, 6020 Innsbruck, Austria
| | - Klaus Wurst
- Department
of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria
| | - Stephan Hohloch
- Department
of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria
| | - Ronald Gust
- Department
of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI−Center
for Molecular Biosciences Innsbruck, CCB—Center for Chemistry
and Biomedicine, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria
| | - Brigitte Kircher
- Immunobiology
and Stem Cell Laboratory, Department of Internal Medicine V (Hematology
and Oncology), Medical University of Innsbruck, Anichstraße 35, 6020 Innsbruck, Austria
- Tyrolean
Cancer Research Institute, Innrain 66, 6020 Innsbruck, Austria
| |
Collapse
|
4
|
Hernández-Pacheco P, Zelada-Guillén GA, Romero-Ávila M, Cañas-Alonso RC, Flores-Álamo M, Escárcega-Bobadilla MV. Enhanced Host-Guest Association and Fluorescence in Copolymers from Copper Salphen Complexes by Supramolecular Internalization of Anions. Chempluschem 2023; 88:e202200310. [PMID: 36175158 DOI: 10.1002/cplu.202200310] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2022] [Revised: 09/13/2022] [Indexed: 11/10/2022]
Abstract
We describe the synthesis, crystallographic characterization of a new Cu-Salphen compound and its use as a host Lewis-acid against guest anions in two versions: a) free molecule, b) copolymerized with methyl methacrylate:n-butyl acrylate (1 : 4-wt.) as protective co-monomers. Higher contents in Cu-Salphen yielded larger and more homogeneous polymer sizes. Polymer size together with glass transitions, heat capacity, thermal degradation, guest-saturation degrees and host-guest species distribution profiles from spectrophotometric titrations explained growths of up to 630-fold in K11 and 180000-fold in K12 for the host's binding site attributable to a solvophobic protection from the macromolecular structure. Spectrofluorimetry revealed blue-shifted×13-16 larger luminescence for Cu-Salphen in the polymers (λem =488-498 nm) than that of the non-polymerized counterpart (λem =510-543 nm) and "turn-on" blue-shifted enhanced fluorescence upon guest association. We propose a cooperative incorporation of the guests occurring from the outer medium toward internally protected binding site pockets in the random coil polymer conformations.
Collapse
Affiliation(s)
- Paulina Hernández-Pacheco
- School of Chemistry, National Autonomous University of Mexico (UNAM), Circuito Escolar s/n, Ciudad Universitaria, Mexico City, 04510, Mexico
| | - Gustavo A Zelada-Guillén
- School of Chemistry, National Autonomous University of Mexico (UNAM), Circuito Escolar s/n, Ciudad Universitaria, Mexico City, 04510, Mexico
| | - Margarita Romero-Ávila
- School of Chemistry, National Autonomous University of Mexico (UNAM), Circuito Escolar s/n, Ciudad Universitaria, Mexico City, 04510, Mexico
| | - Roberto Carlos Cañas-Alonso
- School of Chemistry, National Autonomous University of Mexico (UNAM), Circuito Escolar s/n, Ciudad Universitaria, Mexico City, 04510, Mexico
| | - Marcos Flores-Álamo
- School of Chemistry, National Autonomous University of Mexico (UNAM), Circuito Escolar s/n, Ciudad Universitaria, Mexico City, 04510, Mexico
| | - Martha V Escárcega-Bobadilla
- School of Chemistry, National Autonomous University of Mexico (UNAM), Circuito Escolar s/n, Ciudad Universitaria, Mexico City, 04510, Mexico
| |
Collapse
|
5
|
Ma BN, Baecker D, Descher H, Brandstaetter P, Hermann M, Kircher B, Gust R. Synthesis and biological evaluation of salophen nickel(II) and cobalt(III) complexes as potential anticancer compounds. Arch Pharm (Weinheim) 2023; 356:e2200655. [PMID: 36734178 DOI: 10.1002/ardp.202200655] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2022] [Revised: 01/16/2023] [Accepted: 01/18/2023] [Indexed: 02/04/2023]
Abstract
Recent in vitro investigations of N,N'-bis(salicylidene)-1,2-phenylenediamine (SAP) iron(III) complexes substituted with alkyl (ethyl, propyl, butyl) carboxylates at position 4 in tumor and leukemia cells revealed strong cytotoxic activity. In continuation of this study, analogous nickel(II) and cobalt(III) complexes were synthesized and tested in HL-60 leukemia, and cisplatin-sensitive and -resistant A2780 ovarian cancer cell lines. The biological activity depended on the extent of cellular uptake and the formation of reactive oxygen species (ROS). Inactive [(Ni(II)SAP] complexes (1-3) only marginally accumulated in tumor cells and did not induce ROS. The cellular uptake of [Co(III)SAP]Cl complexes (4-6) into the cells depended on the length of the ester alkyl chain (ethyl, 4 < propyl, 5 < butyl, 6). The cytotoxicity correlated with the presence of ROS. The low cytotoxic complex 4 induced only few ROS, while 5 and 6 caused a good to outstanding antiproliferative activity, exerted high ROS generation, and induced cell death after 48 h. Necrostatin-1 prevented the biological effects, proving necroptosis as part of the mode of action. Interestingly, the effects of 5 and 6 were not reversed by Ferrostatin-1, but even enhanced upon simultaneous application to the tumor cells.
Collapse
Affiliation(s)
- Benjamin N Ma
- Department of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI-Center for Molecular Biosciences Innsbruck, CCB-Center for Chemistry and Biomedicine, University of Innsbruck, Innsbruck, Austria
| | - Daniel Baecker
- Department of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI-Center for Molecular Biosciences Innsbruck, CCB-Center for Chemistry and Biomedicine, University of Innsbruck, Innsbruck, Austria.,Tyrolean Cancer Research Institute, Innsbruck, Austria
| | - Hubert Descher
- Department of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI-Center for Molecular Biosciences Innsbruck, CCB-Center for Chemistry and Biomedicine, University of Innsbruck, Innsbruck, Austria
| | - Philipp Brandstaetter
- Tyrolean Cancer Research Institute, Innsbruck, Austria.,Immunobiology and Stem Cell Laboratory, Department of Internal Medicine V (Hematology and Oncology), Medical University of Innsbruck, Innsbruck, Austria
| | - Martin Hermann
- Department of Anesthesiology and Critical Care Medicine, Medical University of Innsbruck, Innsbruck, Austria
| | - Brigitte Kircher
- Tyrolean Cancer Research Institute, Innsbruck, Austria.,Immunobiology and Stem Cell Laboratory, Department of Internal Medicine V (Hematology and Oncology), Medical University of Innsbruck, Innsbruck, Austria
| | - Ronald Gust
- Department of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI-Center for Molecular Biosciences Innsbruck, CCB-Center for Chemistry and Biomedicine, University of Innsbruck, Innsbruck, Austria
| |
Collapse
|
6
|
Investigations on the Influence of the Axial Ligand in [Salophene]iron(III) Complexes on Biological Activity and Redox Behavior. Int J Mol Sci 2023; 24:ijms24032173. [PMID: 36768497 PMCID: PMC9916684 DOI: 10.3390/ijms24032173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2022] [Revised: 01/09/2023] [Accepted: 01/13/2023] [Indexed: 01/25/2023] Open
Abstract
The [N,N'-disalicylidene-1,2-phenylenediamine]iron(III) ([salophene]iron(III)) derivatives 1-4 with anionic axial ligands (A = Cl-, NO3-, SCN-, CH3COO-) and complexes 5 and 6 with neutral ligands (A = imidazole, 1-methylimidazole) as well as the μ-oxo dimer 7 inhibited proliferation, reduced metabolic activity, and increased mitochondrial reactive oxygen species. Ferroptosis as part of the mode of action was identified by inhibitor experiments, together with induction of lipid peroxidation and diminished mitochondrial membrane potential. No differences in activity were observed for all compounds except 4, which was slightly less active. Electrochemical analyses revealed for all compounds a fast attachment of the solvent dimethyl sulfoxide and a release of the axial ligand A. In contrast, in dichloromethane and acetonitrile, ligand exchange did not take place, as analyzed by measurements of the standard potential for the iron(III/II) redox reaction.
Collapse
|
7
|
Baecker D, Sesli Ö, Knabl L, Huber S, Orth-Höller D, Gust R. Investigating the antibacterial activity of salen/salophene metal complexes: Induction of ferroptosis as part of the mode of action. Eur J Med Chem 2020; 209:112907. [PMID: 33069056 DOI: 10.1016/j.ejmech.2020.112907] [Citation(s) in RCA: 33] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2020] [Revised: 09/29/2020] [Accepted: 10/03/2020] [Indexed: 12/16/2022]
Abstract
The continuous increase of resistant bacteria including Staphylococcus aureus and its methicillin-resistant phenotype (MRSA) is currently one of the major challenges in medicine. Therefore, the discovery of novel lead structures for the design of drugs to fight against infections caused by these bacteria is urgently needed. In this structure-activity relationship study, metal-based drugs were investigated for the treatment of resistant pathogens. The selected Ni(II), Cu(II), Zn(II), Mn(III), and Fe(II/III) complexes differ in their salen- and salophene-type Schiff base ligands. The in vitro activity was evaluated using gram-positive (S. aureus and MRSA) and gram-negative bacteria (Escherichia coli and Pseudomonas aeruginosa). Especially the iron(III) complexes displayed promising antimicrobial effects against gram-positive bacteria, with MIC90 values ranging from 0.781 to 50 μg/mL. Among them, chlorido[(N,N'-bis(salicylidene)-1,2-phenylenediamine]iron(III) (6) showed the best MIC90 value (0.781 μg/mL = 1.93 μmol/L) against S. aureus and MRSA. Complex 6 was comparably potent as ciprofloxacin against S. aureus (0.391 μg/mL = 1.18 μmol/L) and only marginally less active than tetracycline against MRSA (0.391 μg/mL = 0.88 μmol/L). As part of the mode of action, ferroptosis was identified. Applying compound 6 (10 μg/mL), both gram-positive strains grown in PBS were killed within 20 min. This efficacy basically documents that salophene iron(III) complexes represent possible lead structures for the further development of antibacterial metal complexes.
Collapse
Affiliation(s)
- Daniel Baecker
- Department of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI - Center for Molecular Biosciences Innsbruck, University of Innsbruck, CCB - Centrum for Chemistry and Biomedicine, Innrain 80-82, 6020, Innsbruck, Austria
| | - Özcan Sesli
- Department of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI - Center for Molecular Biosciences Innsbruck, University of Innsbruck, CCB - Centrum for Chemistry and Biomedicine, Innrain 80-82, 6020, Innsbruck, Austria; Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstraße 41, 6020, Innsbruck, Austria
| | - Ludwig Knabl
- Institute of Virology, Medical University of Innsbruck, Peter-Mayr-Straße 4b, 6020, Innsbruck, Austria
| | - Silke Huber
- Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstraße 41, 6020, Innsbruck, Austria
| | - Dorothea Orth-Höller
- Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstraße 41, 6020, Innsbruck, Austria
| | - Ronald Gust
- Department of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI - Center for Molecular Biosciences Innsbruck, University of Innsbruck, CCB - Centrum for Chemistry and Biomedicine, Innrain 80-82, 6020, Innsbruck, Austria.
| |
Collapse
|
8
|
Zelada-Guillén GA, Hernández-Pacheco P, Romero-Ávila M, Cañas-Alonso RC, Flores-Álamo M, Escárcega-Bobadilla MV. Acrylic Polymers Containing a Nickel Salphen Complex: An Approach to Supramolecular and Macromolecular Systems. Chempluschem 2020; 85:2546-2556. [PMID: 32945594 DOI: 10.1002/cplu.202000471] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2020] [Revised: 08/21/2020] [Indexed: 11/10/2022]
Abstract
The synthesis, characterization and crystallographic analysis is reported of a new Nickel Salphen complex and its radical copolymerization with n-butyl acrylate and methyl methacrylate to produce novel host macromolecules with tunable association against guest anions. Spectrophotometric titrations of the complex and of the polymers revealed that a supramolecular regulation of guest-binding accessibility was enabled by the number of Ni-Salphen units per chain. The latter content in turn, determined the chain size and molecular weight uniformity upon polymerization, and likely increased the strength in interchain/intrachain non-covalent interactions over the nickel center and the acrylic domains. The study also showed that incorporation of the monomer into the acrylic polymer backbone opened the possibility for the nickel binding site to gain access to host:guest stoichiometric discrimination, switching from 1 : 1 (major) and 1 : 2 (minor) both coexisting for the host when in the free form, to mostly 1 : 2 when in the polymerized version.
Collapse
Affiliation(s)
- Gustavo A Zelada-Guillén
- School of Chemistry, National Autonomous University of Mexico (UNAM), Circuito Escolar s/n, Ciudad Universitaria, Mexico City, 04510, Mexico
| | - Paulina Hernández-Pacheco
- School of Chemistry, National Autonomous University of Mexico (UNAM), Circuito Escolar s/n, Ciudad Universitaria, Mexico City, 04510, Mexico
| | - Margarita Romero-Ávila
- School of Chemistry, National Autonomous University of Mexico (UNAM), Circuito Escolar s/n, Ciudad Universitaria, Mexico City, 04510, Mexico
| | - Roberto Carlos Cañas-Alonso
- School of Chemistry, National Autonomous University of Mexico (UNAM), Circuito Escolar s/n, Ciudad Universitaria, Mexico City, 04510, Mexico
| | - Marcos Flores-Álamo
- School of Chemistry, National Autonomous University of Mexico (UNAM), Circuito Escolar s/n, Ciudad Universitaria, Mexico City, 04510, Mexico
| | - Martha V Escárcega-Bobadilla
- School of Chemistry, National Autonomous University of Mexico (UNAM), Circuito Escolar s/n, Ciudad Universitaria, Mexico City, 04510, Mexico
| |
Collapse
|
9
|
Sagasser J, Ma BN, Baecker D, Salcher S, Hermann M, Lamprecht J, Angerer S, Obexer P, Kircher B, Gust R. A New Approach in Cancer Treatment: Discovery of Chlorido[ N, N'-disalicylidene-1,2-phenylenediamine]iron(III) Complexes as Ferroptosis Inducers. J Med Chem 2019; 62:8053-8061. [PMID: 31369259 DOI: 10.1021/acs.jmedchem.9b00814] [Citation(s) in RCA: 49] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Chlorido[N,N'-disalicylidene-1,2-phenylenediamine]iron(III) complexes generate lipid-based ROS and induce ferroptosis in leukemia and neuroblastoma cell lines. The extent of ferroptosis on the mode of action is regulated by simple modifications of the substituents at the 1,2-phenylenediamine moiety. In HL-60 cells, the unsubstituted lead exclusively caused ferroptosis. For instance, a 4-F substituent shifted the mode of action toward both ferroptosis and necroptosis, while the analogously chlorinated derivative exerted only necroptosis. Remarkably, cell-death in NB1 neuroblastoma cells was solely induced by ferroptosis, independent of the used substituents. The effects were higher than that of the therapeutically applied drug cisplatin. These data clearly demonstrate for the first time that not only iron ions but also iron salophene complexes are potent ferroptosis inducers, which can be optimized as antitumor agents.
Collapse
Affiliation(s)
- Jessica Sagasser
- Department of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI-Center for Molecular Biosciences Innsbruck , University of Innsbruck, CCB-Center for Chemistry and Biomedicine , Innrain 80-82 , 6020 Innsbruck , Austria
| | - Benjamin N Ma
- Department of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI-Center for Molecular Biosciences Innsbruck , University of Innsbruck, CCB-Center for Chemistry and Biomedicine , Innrain 80-82 , 6020 Innsbruck , Austria
| | - Daniel Baecker
- Department of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI-Center for Molecular Biosciences Innsbruck , University of Innsbruck, CCB-Center for Chemistry and Biomedicine , Innrain 80-82 , 6020 Innsbruck , Austria
| | - Stefan Salcher
- Tyrolean Cancer Research Institute , Innrain 66 , 6020 Innsbruck , Austria
| | - Martin Hermann
- Department of Anesthesiology and Critical Care Medicine , Medical University Innsbruck , Anichstraße 35 , 6020 Innsbruck , Austria
| | - Julia Lamprecht
- Tyrolean Cancer Research Institute , Innrain 66 , 6020 Innsbruck , Austria
| | - Stefanie Angerer
- Tyrolean Cancer Research Institute , Innrain 66 , 6020 Innsbruck , Austria.,Immunobiology and Stem Cell Laboratory, Department of Internal Medicine V (Hematology and Oncology) , Medical University Innsbruck , Anichstraße 35 , 6020 Innsbruck , Austria
| | - Petra Obexer
- Tyrolean Cancer Research Institute , Innrain 66 , 6020 Innsbruck , Austria.,Department of Pediatrics II , Medical University Innsbruck , Innrain 66 , 6020 Innsbruck , Austria
| | - Brigitte Kircher
- Tyrolean Cancer Research Institute , Innrain 66 , 6020 Innsbruck , Austria.,Immunobiology and Stem Cell Laboratory, Department of Internal Medicine V (Hematology and Oncology) , Medical University Innsbruck , Anichstraße 35 , 6020 Innsbruck , Austria
| | - Ronald Gust
- Department of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI-Center for Molecular Biosciences Innsbruck , University of Innsbruck, CCB-Center for Chemistry and Biomedicine , Innrain 80-82 , 6020 Innsbruck , Austria
| |
Collapse
|
10
|
Abstract
Many ferrocene complexes have been prepared for their oncological potential. Some derive from molecules with known biological effects (taxanes, podophyllotoxine, artemisine, SAHA, etc.) while others are synthetic molecules selected for their cytotoxic effects (N-alkylaminoferrocenes and ferrocenyl alkylpyridinium). Although these complexes have received a great deal of attention, the field of iron metallodrugs is not limited to them. A number of inorganic complexes of iron(ii) and iron(iii) with possible anticancer effects have also been published, although research into their biological effects is often only at an early stage. This chapter also includes iron chelators, molecules that are administered in non-metallic form but whose cytotoxic species are their coordination complexes of iron generated in vivo. The most emblematic molecule of this family is bleomycin, used as an anticancer agent in many chemotherapies. To these can be added the iron chelates originally synthesized to treat iron overload, some of which have been shown to possess interesting anticancer properties. They have been, and continue to be, the subject of many clinical trials, whether alone or in combination. Thus, the area of iron metallodrugs includes molecules with very different structures and reactivity, studied from a number of different perspectives, but focused on increasing the number of molecules at our disposal for combatting cancer.
Collapse
Affiliation(s)
- Anne Vessieres
- Sorbonne Université, CNRS, Institut Parisien de Chimie Moléculaire, UMR CNRS 8232 4, Place Jussieu F-75005 Paris France
| |
Collapse
|
11
|
Wu YG, Wang DB, Hu JJ, Song XQ, Xie CZ, Ma ZY, Xu JY. An iron( iii) complex selectively mediated cancer cell death: crystal structure, DNA targeting and in vitro antitumor activities. Inorg Chem Front 2019. [DOI: 10.1039/c9qi00030e] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Three new iron(iii) complexes were prepared, and complex 3 exhibited a 14-fold higher selectivity index for HeLa vs. LO2 normal cells than cisplatin.
Collapse
Affiliation(s)
- Yi-Gang Wu
- Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics)
- School of Pharmacy
- Tianjin Medical University
- Tianjin 300070
- China
| | - Dong-Bo Wang
- Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics)
- School of Pharmacy
- Tianjin Medical University
- Tianjin 300070
- China
| | - Juan-Juan Hu
- Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics)
- School of Pharmacy
- Tianjin Medical University
- Tianjin 300070
- China
| | - Xue-Qing Song
- Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics)
- School of Pharmacy
- Tianjin Medical University
- Tianjin 300070
- China
| | - Cheng-Zhi Xie
- Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics)
- School of Pharmacy
- Tianjin Medical University
- Tianjin 300070
- China
| | - Zhong-Ying Ma
- Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics)
- School of Pharmacy
- Tianjin Medical University
- Tianjin 300070
- China
| | - Jing-Yuan Xu
- Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics)
- School of Pharmacy
- Tianjin Medical University
- Tianjin 300070
- China
| |
Collapse
|
12
|
Erxleben A. Transition metal salen complexes in bioinorganic and medicinal chemistry. Inorganica Chim Acta 2018. [DOI: 10.1016/j.ica.2017.06.060] [Citation(s) in RCA: 91] [Impact Index Per Article: 15.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
13
|
Wani WA, Baig U, Shreaz S, Shiekh RA, Iqbal PF, Jameel E, Ahmad A, Mohd-Setapar SH, Mushtaque M, Ting Hun L. Recent advances in iron complexes as potential anticancer agents. NEW J CHEM 2016. [DOI: 10.1039/c5nj01449b] [Citation(s) in RCA: 99] [Impact Index Per Article: 12.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
The iron complexes discussed in this review highlight their promising future as anticancer agents.
Collapse
Affiliation(s)
- Waseem A. Wani
- Institute of Bioproduct Development
- Universiti Teknologi Malaysia
- 81310 UTM Skudai
- Malaysia
| | - Umair Baig
- Center of Excellence for Scientific Research Collaboration with MIT
- King Fahd University of Petroleum and Minerals
- Dhahran 31261
- Saudi Arabia
| | - Sheikh Shreaz
- Oral Microbiology Laboratory
- Department of Bioclinical Sciences
- Faculty of Dentistry
- Health Sciences Center
- Kuwait University
| | - Rayees Ahmad Shiekh
- Department of Chemistry
- Faculty of Science
- Taibah University
- Al Madinah Al Munawarrah
- Saudi Arabia
| | | | - Ehtesham Jameel
- Department of Chemistry
- B. R. Ambedkar Bihar University
- Muzaffarpur
- India
| | - Akil Ahmad
- Center of Lipids Engineering and Applied Research
- Ibnu Sina Institute for Industrial and Scientific Research
- Universiti Teknologi Malaysia
- 81310 UTM Skudai
- Malaysia
| | - Siti Hamidah Mohd-Setapar
- Center of Lipids Engineering and Applied Research
- Ibnu Sina Institute for Industrial and Scientific Research
- Universiti Teknologi Malaysia
- 81310 UTM Skudai
- Malaysia
| | - Md. Mushtaque
- Department of Physical and Molecular Sciences (Chemistry)
- Al-Falah University
- Faridabad
- India
| | - Lee Ting Hun
- Institute of Bioproduct Development
- Universiti Teknologi Malaysia
- 81310 UTM Skudai
- Malaysia
| |
Collapse
|
14
|
Vančo J, Šindelář Z, Dvořák Z, Trávníček Z. Iron-salophen complexes involving azole-derived ligands: A new group of compounds with high-level and broad-spectrum in vitro antitumor activity. J Inorg Biochem 2015; 142:92-100. [DOI: 10.1016/j.jinorgbio.2014.10.002] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2014] [Revised: 10/07/2014] [Accepted: 10/07/2014] [Indexed: 12/19/2022]
|
15
|
Würtenberger I, Follia V, Lerch F, Cwikla C, Fahrner N, Kalchschmidt C, Flögel B, Kircher B, Gust R. Fluorinated Fe(III) Salophene Complexes: Optimization of Tumor Cell Specific Activity and Utilization of Fluorine Labeling for in Vitro Analysis. J Med Chem 2014; 58:588-97. [DOI: 10.1021/jm500986h] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
- Irene Würtenberger
- Department
of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular
Biosciences Innsbruck, CCB—Centrum for Chemistry and Biomedicine, Universität Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria
| | - Valeria Follia
- Department
of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular
Biosciences Innsbruck, CCB—Centrum for Chemistry and Biomedicine, Universität Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria
| | - Fanni Lerch
- Department
of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular
Biosciences Innsbruck, CCB—Centrum for Chemistry and Biomedicine, Universität Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria
| | - Christiane Cwikla
- Pharmazeutische
Chemie, Institut für Pharmazie, Freie Universität Berlin, Königin-Luise-Strasse 2+4, 14195 Berlin, Germany
| | - Nathalie Fahrner
- Department
of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular
Biosciences Innsbruck, CCB—Centrum for Chemistry and Biomedicine, Universität Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria
| | - Christina Kalchschmidt
- Department
of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular
Biosciences Innsbruck, CCB—Centrum for Chemistry and Biomedicine, Universität Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria
| | - Brigitte Flögel
- Immunobiology
and Stem Cell Laboratory, Department of Internal Medicine V (Hematology
and Oncology), Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria
- Tyrolean Cancer Research Institute, Innrain 66, 6020 Innsbruck, Austria
| | - Brigitte Kircher
- Immunobiology
and Stem Cell Laboratory, Department of Internal Medicine V (Hematology
and Oncology), Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria
- Tyrolean Cancer Research Institute, Innrain 66, 6020 Innsbruck, Austria
| | - Ronald Gust
- Department
of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular
Biosciences Innsbruck, CCB—Centrum for Chemistry and Biomedicine, Universität Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria
| |
Collapse
|